Study: NCT00829010

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccine GSK1024850A
Description: Intramuscular injection, administered as 3 or 4 doses

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccine GSK1024850A
Description: Intramuscular injection, administered as 3 or 4 doses

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccine GSK1024850A
Description: Intramuscular injection, administered as 3 or 4 doses

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccine GSK1024850A
Description: Intramuscular injection, administered as 3 or 4 doses

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccine GSK1024850A
Description: Intramuscular injection, administered as 3 or 4 doses

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tritanrix-HepB/Hib
Description: Intramuscular injection, 4 doses

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tritanrix-HepB/Hib
Description: Intramuscular injection, 4 doses

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tritanrix-HepB/Hib
Description: Intramuscular injection, 4 doses

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tritanrix-HepB/Hib
Description: Intramuscular injection, 4 doses

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tritanrix-HepB/Hib
Description: Intramuscular injection, 4 doses

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: measles
Description: Intramuscular injection, 2 doses

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: measles
Description: Intramuscular injection, 2 doses

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: measles
Description: Intramuscular injection, 2 doses

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: measles
Description: Intramuscular injection, 2 doses

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: measles
Description: Intramuscular injection, 2 doses

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rotarix
Description: Oral, 2 doses

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rotarix
Description: Oral, 2 doses

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rotarix
Description: Oral, 2 doses

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rotarix
Description: Oral, 2 doses

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rotarix
Description: Oral, 2 doses

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Local OPV
Description: Oral 4 doses. Given at any time during the study, routinely given concurrently with DTPw-HBV/Hib vaccine

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Local OPV
Description: Oral 4 doses. Given at any time during the study, routinely given concurrently with DTPw-HBV/Hib vaccine

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Local OPV
Description: Oral 4 doses. Given at any time during the study, routinely given concurrently with DTPw-HBV/Hib vaccine

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Local OPV
Description: Oral 4 doses. Given at any time during the study, routinely given concurrently with DTPw-HBV/Hib vaccine

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Local OPV
Description: Oral 4 doses. Given at any time during the study, routinely given concurrently with DTPw-HBV/Hib vaccine